Skip to search.
 Dow Up 1.46% Nasdaq Up 2.24%

Biogen Idec Inc. (BIIB)

-NasdaqGS

149.47 Up 1.72(1.16%) Jul 27, 4:00PM EDT|After Hours: 149.23 Down 0.24 (0.16%) Jul 27, 4:30PM EDT

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 5,048,634   4,716,423   4,377,348  
Cost of Revenue466,780  400,262  382,104  
Gross Profit 4,581,854   4,316,161   3,995,244  
Operating Expenses
Research Development1,219,602  1,248,604  1,283,068  
Selling General and Administrative1,409,969  1,289,611  1,126,938  
Non Recurring19,026  320,129   -  
Others208,566  208,928  289,811  
Total Operating Expenses2,857,163  3,067,272   -  
Operating Income or Loss 1,724,691   1,248,889   1,295,427  
Income from Continuing Operations
Total Other Income/Expenses Net(13,477)(18,983)37,252  
Earnings Before Interest And Taxes1,711,214  1,229,906  1,332,679  
Interest Expense -   -   -  
Income Before Tax1,711,214  1,229,906  1,332,679  
Income Tax Expense444,528  331,333  355,617  
Minority Interest(32,258)106,700  (6,930)
Net Income From Continuing Ops1,234,428  1,005,273  970,132  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,234,428   1,005,273   970,132  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,234,428   1,005,273   970,132  

Currency in USD.